# Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids

> **NCT01504308** · PHASE2,PHASE3 · TERMINATED · sponsor: **Philips Healthcare** · enrollment: 49 (actual)

## Conditions studied

- Uterine Fibroids

## Interventions

- **DEVICE:** MR-HIFU treatment
- **DEVICE:** Sham treatment

## Key facts

- **NCT ID:** NCT01504308
- **Lead sponsor:** Philips Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** It was not possible to enroll patients into the study in a realistic timeframe.
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504308, "Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01504308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*